Publication | Open Access
Structure-based, C2 symmetric inhibitors of HIV protease
211
Citations
0
References
1990
Year
Altmetric Attention ScoreMolecular BiologyPharmacotherapyAntiviral DrugPre-clinical PharmacologySystems PharmacologyMolecular PharmacologyMedicinal ChemistryAntiviral Drug DevelopmentTherapeutic Drug MonitoringC2 Symmetric InhibitorsDrug DevelopmentHivPharmacologyAntiviral CompoundAdvertisement Return ToHiv ProteaseNatural SciencesAntiviral TherapyMedicineDrug DiscoveryQuantitative Pharmacology
ADVERTISEMENT RETURN TO ISSUEPREVArticleNEXTStructure-based, C2 symmetric inhibitors of HIV proteaseDale J. Kempf, Daniel W. Norbeck, LynnMarie Codacovi, Xiu Chun Wang, William E. Kohlbrenner, Norman E. Wideburg, Deborah A. Paul, Mark F. Knigge, Sudthida Vasavanonda, and Cite this: J. Med. Chem. 1990, 33, 10, 2687–2689Publication Date (Print):October 1, 1990Publication History Published online1 May 2002Published inissue 1 October 1990https://pubs.acs.org/doi/10.1021/jm00172a002https://doi.org/10.1021/jm00172a002research-articleACS PublicationsRequest reuse permissionsArticle Views465Altmetric-Citations187LEARN ABOUT THESE METRICSArticle Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.Citations are the number of other articles citing this article, calculated by Crossref and updated daily. Find more information about Crossref citation counts.The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on the Altmetric Attention Score and how the score is calculated. Share Add toView InAdd Full Text with ReferenceAdd Description ExportRISCitationCitation and abstractCitation and referencesMore Options Share onFacebookTwitterWechatLinked InRedditEmail Other access optionsGet e-Alertsclose Get e-Alerts